These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 36754490)
21. Cardiovascular diseases and risk factors knowledge and awareness in people with type 2 diabetes mellitus: a global evaluation. Saeedi P; Karuranga S; Hammond L; Kaundal A; Malanda B; Prystupiuk M; Matos P Diabetes Res Clin Pract; 2020 Jul; 165():108194. PubMed ID: 32389743 [TBL] [Abstract][Full Text] [Related]
22. Intensive glycaemic control in type 2 diabetes mellitus: does it improve cardiovascular outcomes? Reddy SV; Bhatia E Natl Med J India; 2011; 24(1):21-7. PubMed ID: 21608354 [TBL] [Abstract][Full Text] [Related]
23. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. ; Wing RR Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408 [TBL] [Abstract][Full Text] [Related]
24. Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes. Gunathilake W; Song S; Sridharan S; Fernando DJ; Idris I QJM; 2010 Nov; 103(11):881-4. PubMed ID: 20675397 [TBL] [Abstract][Full Text] [Related]
25. Glycemia management and cardiovascular risk in type 2 diabetes: an evolving perspective. Ismail-Beigi F; Moghissi ES Endocr Pract; 2008; 14(5):639-43. PubMed ID: 18753110 [TBL] [Abstract][Full Text] [Related]
26. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes. Dailey G Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233 [TBL] [Abstract][Full Text] [Related]
27. Is the risk and nature of CVD the same in type 1 and type 2 diabetes? Duca L; Sippl R; Snell-Bergeon JK Curr Diab Rep; 2013 Jun; 13(3):350-61. PubMed ID: 23519720 [TBL] [Abstract][Full Text] [Related]
28. Association of serum angiopoietin-like protein 2 with elevated risk of cardiovascular diseases in subjects with type 2 diabetes. El-Lebedy D J Diabetes Complications; 2019 Nov; 33(11):107421. PubMed ID: 31484627 [TBL] [Abstract][Full Text] [Related]
29. Cardiovascular disease morbidity and mortality in patients with type 1 diabetes mellitus : management strategies. Soedamah-Muthu SS; Stehouwer CD Treat Endocrinol; 2005; 4(2):75-86. PubMed ID: 15783245 [TBL] [Abstract][Full Text] [Related]
30. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes. Boersma HE; van Waateringe RP; van der Klauw MM; Graaff R; Paterson AD; Smit AJ; Wolffenbuttel BHR BMC Endocr Disord; 2021 Jan; 21(1):14. PubMed ID: 33435948 [TBL] [Abstract][Full Text] [Related]
32. Impact of metabolic surgery on 10-year cardiovascular disease risk in Chinese individuals with type 2 diabetes. Ke Z; Li F; Zhou X; Sun F; Zhu Z; Tong W Surg Obes Relat Dis; 2021 Mar; 17(3):498-507. PubMed ID: 33358863 [TBL] [Abstract][Full Text] [Related]
33. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Wong ND; Sattar N Nat Rev Cardiol; 2023 Oct; 20(10):685-695. PubMed ID: 37193856 [TBL] [Abstract][Full Text] [Related]
34. The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease. Zhang Y; Liu C; Xu Y; Wang Y; Dai F; Hu H; Jiang T; Lu Y; Zhang Q Front Endocrinol (Lausanne); 2022; 13():1036146. PubMed ID: 36778594 [TBL] [Abstract][Full Text] [Related]
35. Are we there yet? Increasing use of cardioprotective antihyperglycemic agents in patients with T2D and CVD or CV risk in the United States. Mody R; Meyers J; Yu M; Davis K; Levine JA Curr Med Res Opin; 2022 Nov; 38(11):1785-1795. PubMed ID: 35758147 [TBL] [Abstract][Full Text] [Related]
36. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies. Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714 [TBL] [Abstract][Full Text] [Related]
37. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Wei M; Gaskill SP; Haffner SM; Stern MP Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614 [TBL] [Abstract][Full Text] [Related]
38. Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem? Neppala S; Rajan J; Yang E; DeFronzo RA Curr Cardiol Rep; 2024 Jun; 26(6):623-633. PubMed ID: 38634964 [TBL] [Abstract][Full Text] [Related]